ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Loop Capital Downgrades Zimmer Biomet (ZBH) to Hold
March 2, 2022 7:17 AM ESTLoop Capital analyst Jason H. Wittes downgraded Zimmer Biomet (NYSE: ZBH) from Buy to Hold with a price target of $130.00.
The analyst comments "Downgrading to a Hold Post ZimVie Split...We are downgrading ZBH post ZimVie split to Hold. While the... More
